Immunophenotyping
"Immunophenotyping" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.
Descriptor ID |
D016130
|
MeSH Number(s) |
E01.370.225.812.447 E05.200.812.447 E05.478.594.450
|
Concept/Terms |
Immunophenotyping- Immunophenotyping
- Immunophenotypings
- Subtypings, Immunologic
- Subtyping, Immunologic
- Immunologic Subtyping
- Immunologic Subtypings
Lymphocyte Subtyping- Lymphocyte Subtyping
- Lymphocyte Subtypings
- Subtyping, Lymphocyte
- Subtypings, Lymphocyte
Lymphocyte Immunophenotyping- Lymphocyte Immunophenotyping
- Immunophenotyping, Lymphocyte
- Immunophenotypings, Lymphocyte
- Lymphocyte Immunophenotypings
- Lymphocyte Phenotyping
- Lymphocyte Phenotypings
- Phenotyping, Lymphocyte
- Phenotypings, Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Immunophenotyping".
Below are MeSH descriptors whose meaning is more specific than "Immunophenotyping".
This graph shows the total number of publications written about "Immunophenotyping" by people in UAMS Profiles by year, and whether "Immunophenotyping" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 1 | 1 | 2 | 2021 | 0 | 2 | 2 | 2020 | 0 | 2 | 2 | 2019 | 0 | 1 | 1 | 2018 | 2 | 6 | 8 | 2017 | 0 | 4 | 4 | 2016 | 0 | 3 | 3 | 2015 | 0 | 3 | 3 | 2014 | 0 | 3 | 3 | 2013 | 0 | 2 | 2 | 2012 | 0 | 3 | 3 | 2011 | 0 | 1 | 1 | 2010 | 0 | 1 | 1 | 2009 | 1 | 0 | 1 | 2008 | 0 | 2 | 2 | 2007 | 1 | 4 | 5 | 2006 | 0 | 4 | 4 | 2005 | 0 | 1 | 1 | 2004 | 1 | 1 | 2 | 2003 | 0 | 5 | 5 | 2002 | 0 | 9 | 9 | 2001 | 1 | 4 | 5 | 2000 | 0 | 7 | 7 | 1999 | 0 | 5 | 5 | 1998 | 1 | 5 | 6 | 1997 | 0 | 3 | 3 | 1995 | 0 | 1 | 1 | 1993 | 0 | 2 | 2 | 1992 | 0 | 1 | 1 | 1991 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunophenotyping" by people in Profiles over the past ten years.
-
Pinho ACO, Barbosa P, Lazaro A, Tralh?o JG, Pereira MJ, Paiva A, Laranjeira P, Carvalho E. Identification and characterization of circulating and adipose tissue infiltrated CD20+T cells from subjects with obesity that undergo bariatric surgery. Immunol Lett. 2024 Oct; 269:106911.
-
Hamilton MP, Craig E, Gentille Sanchez C, Mina A, Tamaresis J, Kirmani N, Ehlinger Z, Syal S, Good Z, Sworder B, Schroers-Martin J, Lu Y, Muffly L, Negrin RS, Arai S, Lowsky R, Meyer E, Rezvani AR, Shizuru J, Weng WK, Shiraz P, Sidana S, Bharadwaj S, Smith M, Dahiya S, Sahaf B, Kurtz DM, Mackall CL, Tibshirani R, Alizadeh AA, Frank MJ, Miklos DB. CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity. Blood Adv. 2024 Jun 25; 8(12):3314-3326.
-
Carrillo LF. Fluorescent-Activated Cell Sorting (Flow Cytometry). Methods Mol Biol. 2022; 2422:271-281.
-
Wier E, Asada M, Wang G, Alphonse MP, Li A, Hintelmann C, Sweren E, Youn C, Pielstick B, Ortines R, Lyu C, Daskam M, Miller LS, Archer NK, Garza LA. Neutrophil extracellular traps impair regeneration. J Cell Mol Med. 2021 11; 25(21):10008-10019.
-
Yu S, Tripod M, Atasoy U, Chen J. HuR Plays a Positive Role to Strengthen the Signaling Pathways of CD4+ T Cell Activation and Th17 Cell Differentiation. J Immunol Res. 2021; 2021:9937243.
-
Yang Y, Kellermayer D, Calleroz A, Golardi N, Finch C, Padmanabhan V, Yared M, Szigeti R. Flow cytometry is superior to conventional cytology in the surveillance evaluation of paucicellular cerebrospinal fluids. Leuk Lymphoma. 2021 05; 62(5):1278-1280.
-
Bakhshwin A, Berry RS, Cox RM, Li R, Reynolds JP, Rubin BP, McKenney JK. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma. Pathology. 2020 Oct; 52(6):643-648.
-
D'Almeida Costa F, Dias TM, Lombardo KA, Raghunathan A, Giannini C, Kenyon L, Saad AG, Gokden M, Burger PC, Montgomery EA, Rodriguez FJ. Intracranial cellular schwannomas: a clinicopathological study of 20 cases. Histopathology. 2020 Jan; 76(2):275-282.
-
Levy H, Jia S, Pan A, Zhang X, Kaldunski M, Nugent ML, Reske M, Feliciano RA, Quintero D, Renda MM, Woods KJ, Murkowski K, Johnson K, Verbsky J, Dasu T, Ideozu JE, McColley S, Quasney MW, Dahmer MK, Avner E, Farrell PM, Cannon CL, Jacob H, Simpson PM, Hessner MJ. Identification of molecular signatures of cystic fibrosis disease status with plasma-based functional genomics. Physiol Genomics. 2019 01 01; 51(1):27-41.
-
Adams HC, Stevenaert F, Krejcik J, Van der Borght K, Smets T, Bald J, Abraham Y, Ceulemans H, Chiu C, Vanhoof G, Usmani SZ, Plesner T, Lonial S, Nijhof I, Lokhorst HM, Mutis T, van de Donk NWCJ, Sasser AK, Casneuf T. High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action. Cytometry A. 2019 03; 95(3):279-289.
-
El Chaer F, Ali OM, Sausville EA, Law JY, Lee ST, Duong VH, Baer MR, Koka R, Singh ZN, Wong J, Yared JA, Griffiths EA, Emadi A. Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab. Am J Hematol. 2019 01; 94(1):E7-E8.
-
Bhutani M, Foureau D, Zhang Q, Robinson M, Wynn AS, Steuerwald NM, Druhan LJ, Guo F, Rigby K, Turner M, Slaughter D, Friend R, Atrash S, Symanowski JT, Avalos BR, Copelan EA, Voorhees PM, Usmani SZ. Peripheral Immunotype Correlates with Minimal Residual Disease Status and Is Modulated by Immunomodulatory Drugs in Multiple Myeloma. Biol Blood Marrow Transplant. 2019 03; 25(3):459-465.
-
B?dker JS, Br?ndum RF, Schmitz A, Sch?nherz AA, Jespersen DS, S?nderk?r M, Vesteghem C, Due H, N?rgaard CH, Perez-Andres M, Samur MK, Davies F, Walker B, Pawlyn C, Kaiser M, Johnson D, Bertsch U, Broyl A, van Duin M, Shah R, Johansen P, N?rgaard MA, Samworth RJ, Sonneveld P, Goldschmidt H, Morgan GJ, Orfao A, Munshi N, Johnson HE, El-Galaly T, Dybk?r K, B?gsted M. A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis. Blood Adv. 2018 09 25; 2(18):2400-2411.
-
Bakshi RK, Gupta K, Jordan SJ, Chi X, Lensing SY, Press CG, Geisler WM. An Adaptive Chlamydia trachomatis-Specific IFN-?-Producing CD4+ T Cell Response Is Associated With Protection Against Chlamydia Reinfection in Women. Front Immunol. 2018; 9:1981.
-
Zuo M, Shen H, Yin J, Wang W, Zhang Y, Zhou DB, Zhang W. Expression of PD-1 on peripheral blood Treg cells is related to the diagnosis, prognosis and treatment of T cell non-Hodgkin lymphoma. Leuk Res. 2018 07; 70:56-61.
-
Post SR, Post GR, Nikolic D, Owens R, Insuasti-Beltran G. Development of an unbiased, semi-automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates. Cytometry B Clin Cytom. 2018 09; 94(5):602-610.
-
Boddu P, Oviedo SP, Rausch CR, Yam C, Daver N, Kantarjian H, Kadia TM. PET-CT in AML-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma. 2018 06; 59(6):1486-1489.
-
Ogendi BMO, Bakshi RK, Sabbaj S, Brown L, Lee JY, Kapil R, Geisler WM. Distinct peripheral vs mucosal T-cell phenotypes in chlamydia-infected women. Am J Reprod Immunol. 2017 Dec; 78(6).
-
Pina-Oviedo S, Miranda RN, Lin P, Manning JT, Medeiros LJ. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature. Hum Pathol. 2017 10; 68:136-146.
-
Wankhade UD, Rane SG. Flow Cytometry Assisted Isolation of Adipose Tissue Derived Stem Cells. Methods Mol Biol. 2017; 1566:17-24.
-
Zhang W, Bai JF, Zuo MX, Cao XX, Chen M, Zhang Y, Han X, Zhong DR, Zhou DB. PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma. Cancer Med. 2016 11; 5(11):3077-3084.
-
V?tsveen TK, B?rset M, Dikic A, Tian E, Micci F, Lid AH, Meza-Zepeda LA, Coward E, Waage A, Sundan A, Kuehl WM, Holien T. VOLIN and KJON-Two novel hyperdiploid myeloma cell lines. Genes Chromosomes Cancer. 2016 11; 55(11):890-901.
-
Wong HK. STAT Assays with a TWIST: Differentiating S?zary Syndrome?from?Erythrodermic Inflammatory Dermatitis. J Invest Dermatol. 2016 07; 136(7):1313-1315.
-
Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, Garc?a-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF. Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance. Blood. 2016 Apr 14; 127(15):1896-906.
-
Bam R, Khan S, Ling W, Randal SS, Li X, Barlogie B, Edmondson R, Yaccoby S. Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow. BMC Cancer. 2015 Nov 06; 15:864.
-
Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopathol. 2015 Nov; 37(11):809-21.
-
Doherty TA, Baum R, Newbury RO, Yang T, Dohil R, Aquino M, Doshi A, Walford HH, Kurten RC, Broide DH, Aceves S. Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis. J Allergy Clin Immunol. 2015 Sep; 136(3):792-794.e3.
-
Jiwani S, Bornhost J, Alapat D. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains. Int J Clin Exp Pathol. 2015; 8(7):8536-44.
-
Abdallah AO, Bansal M, Kemp SA, Schichman SA, Xiang Z. A unique presentation of unilateral pleural effusion in a patient with a high-grade plasma cell neoplasm. Leuk Lymphoma. 2015; 56(10):2989-91.
-
Cetin N, Pandey S, Lorsbach RB. Immature lymphoid cells are a consistent feature of chylothorax in neonates and infants: cytologic features and flow cytometry aid in its distinction from lymphoblastic leukemia/lymphoma. Diagn Cytopathol. 2015 Apr; 43(4):335-8.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|